Hormone concentration measurement in intracranial dural arteriovenous fistulae.

DAVF cavernous sinus endovascular estradiol intracranial dural arteriovenous fistulae sex hormone transverse sinus

Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
15 Feb 2024
Historique:
received: 03 12 2023
revised: 08 02 2024
accepted: 09 02 2024
medline: 18 2 2024
pubmed: 18 2 2024
entrez: 17 2 2024
Statut: aheadofprint

Résumé

Intracranial dural arteriovenous fistulae (DAVF) represent a subset of cerebral vascular malformations associated with significant morbidity and mortality. In Japan, DAVF exhibits sex-based differences in anatomical distribution, with female predominance in the cavernous sinus (CS) and male predominance in the transverse sinus (TS). Nevertheless, the pathophysiology of DAVF is not fully understood, and hormonal influences are hypothesized to play a role in its development. This study aimed to investigate changes in the concentrations of sex steroid hormones between intracranial and peripheral sampling sites in CS- and TS-DAVF patients. We recruited 19 patients with CS-DAVF (n=12) and TS-DAVF (n=7) in this study. Blood hormone measurements were obtained from peripheral and jugular bulb (JB) samples during endovascular intervention. Hormone concentrations were analyzed using enzyme-linked immunosorbent assay kits, and statistical analyses were performed. Our study revealed a higher prevalence of CS-DAVF in females and TS-DAVF in males, which is consistent with previous studies. Estradiol concentration was significantly lower in the JB compared with in the periphery in both CS- and TS-DAVF patients. This decrease in estradiol was observed irrespective of the patient's sex and independent of FSH levels. These findings indicate a local decrease in estradiol levels within the intracranial vasculature of DAVF patients. This suggests a potential multifactorial role of estradiol in the pathomechanism of DAVFs, warranting further investigation to understand its influence on DAVF formation and potential targeted therapies, thereby enhancing patient outcomes.

Identifiants

pubmed: 38367858
pii: S1878-8750(24)00250-X
doi: 10.1016/j.wneu.2024.02.052
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Auteurs

Asuka Elisabeth Kropp (AE)

Department of Neurosurgery, Nagoya University of Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya Aichi, 466-8550, Japan.

Masahiro Nishihori (M)

Department of Neurosurgery, Nagoya University of Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya Aichi, 466-8550, Japan. Electronic address: nishihori@med.nagoya-u.ac.jp.

Takashi Izumi (T)

Department of Neurosurgery, Nagoya University of Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya Aichi, 466-8550, Japan.

Shunsaku Goto (S)

Department of Neurosurgery, Nagoya University of Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya Aichi, 466-8550, Japan.

Kinya Yokoyama (K)

Department of Neurosurgery, Nagoya University of Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya Aichi, 466-8550, Japan.

Ryuta Saito (R)

Department of Neurosurgery, Nagoya University of Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya Aichi, 466-8550, Japan.

Classifications MeSH